We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Buys

Rank Stock Value
1
COLD icon
Americold
COLD
+$166M
2
OHI icon
Omega Healthcare
OHI
+$102M
3
SUI icon
Sun Communities
SUI
+$98.2M
4
AIRC
Apartment Income REIT Corp.
AIRC
+$97.3M
5
DOC icon
Healthpeak Properties
DOC
+$93.5M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
1101
BioCryst Pharmaceuticals
BCRX
$2.45B
$2K ﹤0.01%
332
-654
-66% -$3.37K
BDTX icon
1102
Black Diamond Therapeutics
BDTX
$96.8M
$2K ﹤0.01%
+68
New +$2.23K
CDXS icon
1103
Codexis
CDXS
$160M
$2K ﹤0.01%
+111
New +$1.83K
CGEN icon
1104
Compugen
CGEN
$213M
$2K ﹤0.01%
156
-278
-64% -$3.83K
CHRS icon
1105
Coherus Oncology
CHRS
$217M
$2K ﹤0.01%
135
-261
-66% -$4.65K
COLL icon
1106
Collegium Pharmaceutical
COLL
$1.18B
$2K ﹤0.01%
76
-104
-58% -$2.03K
CSTL icon
1107
Castle Biosciences
CSTL
$734M
$2K ﹤0.01%
37
-59
-61% -$3.2K
ENTA icon
1108
Enanta Pharmaceuticals
ENTA
$364M
$2K ﹤0.01%
38
-73
-66% -$3.21K
GBIO
1109
DELISTED
Generation Bio
GBIO
$2K ﹤0.01%
+9
New +$2.89K
INVA icon
1110
Innoviva
INVA
$1.58B
$2K ﹤0.01%
191
-381
-67% -$4.11K
ITOS
1111
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
+66
New +$1.75K
KPTI icon
1112
Karyopharm Therapeutics
KPTI
$158M
$2K ﹤0.01%
9
-19
-68% -$4.4K
KRRO icon
1113
Korro Bio
KRRO
$146M
$2K ﹤0.01%
+1
New +$1.32K
KRYS icon
1114
Krystal Biotech
KRYS
$10.7B
$2K ﹤0.01%
+37
New +$1.85K
MGNX icon
1115
MacroGenics
MGNX
$236M
$2K ﹤0.01%
106
-204
-66% -$4.7K
NRIX icon
1116
Nurix Therapeutics
NRIX
$2.46B
$2K ﹤0.01%
+73
New +$2.42K
OMER icon
1117
Omeros
OMER
$845M
$2K ﹤0.01%
116
-193
-62% -$2.36K
ORIC icon
1118
Oric Pharmaceuticals
ORIC
$1.19B
$2K ﹤0.01%
+69
New +$1.98K
PASG icon
1119
Passage Bio
PASG
$14.6M
$2K ﹤0.01%
+4
New +$1.6K
PLRX icon
1120
Pliant Therapeutics
PLRX
$65.6M
$2K ﹤0.01%
+67
New +$1.68K
PTGX icon
1121
Protagonist Therapeutics
PTGX
$8.6B
$2K ﹤0.01%
81
-115
-59% -$2.48K
QNCX icon
1122
Quince Therapeutics
QNCX
$21.9M
– –
0
– –
RNAM
1123
DELISTED
Avidity Biosciences
RNAM
$2K ﹤0.01%
+71
New +$2.07K
RPTX
1124
DELISTED
Repare Therapeutics
RPTX
$2K ﹤0.01%
+69
New +$2.06K
RYTM icon
1125
Rhythm Pharmaceuticals
RYTM
$7.38B
$2K ﹤0.01%
83
-165
-67% -$4.19K
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.